MAC Stock Recent News

ST. HELIER, Jersey--(BUSINESS WIRE)--MAC Copper Limited ARBN 671 963 198 (NYSE:MTAL; ASX:MAC) MAC Copper Limited ARBN 671 963 198 (NYSE: MTAL; ASX: MAC), a private limited company incorporated under the laws of Jersey, Channel Islands (“MAC” or the “Company”) will release its fourth quarter 2024 results on Tuesday, January 28, 2025 after market close (New York time) / Wednesday, January 29, 2025 before market open (Sydney time). Conference Call The Company will host a conference call and webcas.

Macerich has rallied heavily over the last year as market enthusiasm builds over its Path Forward Plan. The REIT is currently trading for 13.5x times its annualized third-quarter FFO and offers a modest 3.31% dividend yield. The November equity offering should be accretive, but revenue is set to dip in future quarters on asset sales and givebacks.

MAC''s portfolio of premium shopping centers, focus on omnichannel retailing and development of mixed-use assets are strengths despite growing e-commerce adoption.

A2MAC1 Selects Microsoft Azure as its Preferred Cloud Platform and Launches its Cost and Sustainability Suite in the Azure Marketplace.

SANTA MONICA, Calif., Oct. 02, 2024 (GLOBE NEWSWIRE) -- WHAT: Macerich (NYSE: MAC) Schedules Third Quarter 2024 Earnings Release and Conference Call

A portfolio of premium shopping centers, focus on omnichannel retailing and developing mixed-use assets, will likely aid MAC despite growing e-commerce adoption.

Macerich (MAC) reported earnings 30 days ago. What's next for the stock?

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform today announced topline results from the Phase 2 part of the EBO-301 Phase 2/3 study evaluating epetraborole on top of an optimized background regimen (OBR) in treatment-refractory MAC lung disease. The Phase 2 part of the study met its primary objective of demonstrating the poten.

Macerich's (MAC) Q2 results reflect an increase in same-center net operating income. The company also continues with its portfolio quality refining and balance sheet improving efforts.

MAC reported FFO numbers for its second quarter that dipped 1 cent per share year-over-year. The dividend is 230% covered by FFO but still sits almost 80% below its pre-pandemic level. Management has not made it clear that their path forward plan intends to boost the capacity for more substantial dividend payouts.